LifeMD, Inc. (LFMD) stock
Close on Nov 11, 2026Market cap $85.80MP/E –Yield –
LifeMD, Inc. grew revenue 3.8% to $164.70M over the twelve months to Jun 30, 2026. Free cash flow was -$11.06M, down 161.6% from a year earlier. At the latest close the market valued the company at $85.80M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $85.80M
- P/E ratio
- –
- Price to sales
- 0.52
- Price to book
- 10.77
- Dividend yield
- –
- Free cash flow yield
- -12.89%
Fundamentals
- Revenue
- $164.70M
- Net income
- $201.01K
- EPS, diluted
- -$0.05
- Free cash flow
- -$11.06M
- Book value per share
- $0.17
- Diluted shares
- 48M
Trading
- Next earnings
- Nov 16, 2026 (estimated, after the close)
- Previous close
- $1.74
- Open
- $1.74
- Day's range
- $1.67 – $1.79
- Volume
- 1,354,903
- Average volume (20 days)
- 876,691
- Index membership
- Russell 2000 (since Sep 2024)
- Beta (5 years)
- 1.71
- 52-week range
- $1.67 – $5.38
- RSI (14 days)
- 31.8
- Volatility (1 year)
- 83.3%
- Relative volume
- 1.63×
- WACC
- 13.4%
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2013, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LFMD | S&P 500 | Difference | LFMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -32.3% | -2.4% | −29.9 pts | ||
| 3 months | -47.3% | -1.2% | −46.2 pts | ||
| Year to date | -47.8% | +12.3% | −60.1 pts | ||
| 1 year | -64.8% | +12.4% | −77.3 pts | ||
| 3 years | -74.1% | +78.8% | −152.9 pts | -36.3% | +21.4% |
| 5 years | -63.1% | +75.2% | −138.2 pts | -18.1% | +11.9% |
| 10 years | +36.9% | +311.1% | −274.2 pts | +3.2% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases LifeMD filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Results
- Results
About LifeMD
Services-Offices & Clinics of Doctors of Medicine
LifeMD, Inc. operates as a direct-to-patient healthcare company that provides virtual medical care and pharmacy services. The company delivers clinical consultations alongside prescription and over-the-counter treatments across various health areas, including primary care, men's and women's health, hormone therapy, weight management, insomnia, dermatology, and cardiology. Most offerings follow a subscription model, serving individual patient subscribers directly.
Company profile, executives and historyLifeMD stock: common questions
What is LifeMD's stock price?
LFMD closed at $1.78 on Nov 11, 2026, up 2.30% on the day. Over the past 52 weeks it traded between $1.67 and $5.38.
What is LifeMD's market cap?
LifeMD was worth $85.80M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LFMD's P/E ratio?
LifeMD lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.05), so it has no meaningful P/E ratio.
How much revenue does LifeMD make?
LifeMD reported revenue of $164.70M for the twelve months to Jun 30, 2026, up 3.8% from a year earlier.
Does LifeMD pay a dividend?
No. LifeMD has not paid a cash dividend over the last twelve months.
When does LifeMD report earnings next?
LifeMD is expected to report Q3 FY2026 results on Nov 16, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has LFMD stock performed over the past year?
Including dividends, LFMD returned -64.8% over the past year, against +12.4% for the S&P 500.
Who are LifeMD's competitors?
Companies most similar to LifeMD by business, industry and size include SBC, AIRS, HIMS, STLN, TDOC.
See a number that looks wrong?